Since 2 February 2026, FDA's quality system rules for medical devices have been aligned with ISO 13485. The regulation is still 21 CFR Part 820, but it is now called the Quality Management System Regulation (QMSR). It replaces the Quality System Regulation (QSR).
What is the QMSR?
The QMSR sets the quality management system (QMS) requirements for manufacturers of finished devices that are commercially distributed in the U.S. Its aim is that devices consistently meet their applicable requirements and specifications. FDA also wanted its framework to line up with those of other regulators.
A finished device is any device or accessory that is suitable for use or capable of functioning, whether or not it is packaged, labeled or sterilized. Accessories are included, so makers of items such as blood tubing or diagnostic x-ray components are covered. The rule does not extend to component manufacturers.
What changed from the QSR
- ISO 13485:2016 is now incorporated by reference. It forms the core of Part 820. Clause 3 of ISO 9000:2015 is incorporated too, for terms and definitions.
- The structure is much shorter. The QSR had 15 subparts. The QMSR keeps Subpart A (General Provisions) and Subpart B (Supplemental Provisions). Subparts C to O are reserved, and ISO 13485 covers those topics instead.
- FDA's own requirements still sit on top of ISO 13485. If an ISO clause conflicts with the FD&C Act or its regulations, the Act and regulations win.
- The DHF, DMR and DHR terms are retired. Their content now sits in ISO concepts such as the medical device file and the design and development file.
- Risk management is explicit. ISO 13485 specifically requires it, and it runs through the lifecycle, from design to supplier control to CAPA decisions.
FDA's supplemental provisions
These are the parts of Part 820 that go beyond ISO 13485:
| Provision | What it adds |
|---|---|
| 820.3 | Definitions that ISO leaves out or that FDA wants to read differently. For example, "safety and performance" is read as "safety and effectiveness." |
| 820.10 | Links the QMS to other FDA rules: UDI (Part 830), traceability (Part 821), medical device reporting (Part 803) and corrections and removals (Part 806). It also limits design and development requirements to devices under design controls (Class II, Class III and certain Class I). |
| 820.35 | Content requirements for complaint records and service records, including when complaints must be investigated. |
| 820.45 | Labeling and packaging controls, including checks of labeling accuracy before release. FDA considered ISO 13485's controls insufficient here. |
Where the old QSR requirements now sit
| Former QSR section | Now found in |
|---|---|
| Management responsibility (820.20) | ISO 13485, clause 5 |
| Quality audit (820.22) | ISO 13485, 8.2.4 |
| Personnel (820.25) | ISO 13485, 6.2 |
| Design controls (820.30) | ISO 13485, 7.3 |
| Document controls (820.40) | ISO 13485, 4.2.4 |
| Purchasing controls (820.50) | ISO 13485, 7.4 |
| Process validation (820.75) | ISO 13485, 7.5.6 |
| Nonconforming product (820.90) | ISO 13485, 8.3 |
| CAPA (820.100) | ISO 13485, 8.5.2 and 8.5.3 |
| Labeling (820.120) | ISO 13485, 7.5.1 plus 820.45 |
| Device master record (820.181) | Medical device file (ISO 13485, 4.2.3) |
| Device history record (820.184) | Production and acceptance records (ISO 13485, 7.5 and 8.2.6) |
| Complaint files (820.198) | ISO 13485, 8.2.2 plus 820.35 |
FDA describes the two sets of requirements as substantially similar, but the clauses do not map one-to-one.
What it means for inspections
- FDA stopped using the Quality System Inspection Technique (QSIT) on 2 February 2026. Inspections now follow Compliance Program 7382.850.
- Investigators can review QMS records, including ones created before 2 February 2026.
- Management review, internal audit and supplier audit reports are now open to FDA. The QSR had exempted them (820.180(c)). The QMSR does not carry that exemption forward.
- FDA inspections are risk-based and assess compliance with FDA regulations. They do not follow MDSAP audit procedures.
Is ISO 13485 certification required?
No. FDA does not require a certificate of conformance to ISO 13485, doesn't issue one, and won't rely on one in place of an inspection. Certification can still help if you sell in other markets or take part in MDSAP. Certification is optional, compliance is mandatory.
Exempt devices
Some device types are exempt from the QMS requirements under their classification regulations (21 CFR Parts 862 to 892). Even so, the complaint file and records requirements of 820.35 still apply to those manufacturers.
How to prepare
- Get the standards. Obtain ISO 13485:2016 and Clause 3 of ISO 9000:2015. FDA offers read-only access, but you need to buy a copy to download one.
- Map your procedures. Compare your current QSR-based procedures against ISO 13485 and the supplemental provisions and note the gaps.
- Update your language. Replace DHF, DMR and DHR with the new constructs across procedures, templates and training.
- Check complaint and service records. Make sure they meet the content requirements of 820.35.
- Add label checks. Build in the labeling accuracy checks required before release (820.45).
- Validate QMS software. Software used in the QMS should be validated before first use.
- Update supplier agreements. Outsourced processes that affect product conformity need written quality agreements, and suppliers should notify you of changes.
- Get audit-ready. Management review, internal audit and supplier audit records are now inspectable, so check that they are complete and written in a factual, professional tone.
- Link procedures to records. For every procedure, be able to show records that prove it is followed.
Need help with QMSR readiness?
Tell us about your current QMS, and we'll help you identify gaps against the QMSR and prepare for an inspection.